Targeting DUSP5 suppresses malignant phenotypes of BRAF-mutant thyroid cancer cells and improves their response to sorafenib
Article in Endocrine (April 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in Endocrine (April 2024)
Article in The Journal of Clinical Endocrinology & Metabolism (March 2024)
Article in Oncology Letters (January 2024)